Navigation Links
Arena Pharmaceuticals Announces First Quarter 2009 Financial Results
Date:5/11/2009

ired under applicable law.

    Contacts:  Jack Lief                           Mary Claire Duch
               President and Chief Executive       WeissComm Partners
                Officer                            Media Relations
               Cindy McGee                         212.301.7228
               Senior Communications Associate

               Arena Pharmaceuticals, Inc.
               858.453.7200, ext. 1479



                          Arena Pharmaceuticals, Inc.
               Condensed Consolidated Statements of Operations
                   (In thousands, except per share amounts)

                                               Three months ended
                                                    March 31,
                                                2009         2008
                                                  (unaudited)
    Revenues
    Manufacturing services                    $1,418       $2,019
    Collaborative agreements                   1,240          590
      Total revenues                           2,658        2,609

    Operating Expenses
    Cost of manufacturing services             1,354        2,330
    Research and development                  42,620       47,368
    General and administrative                 7,642        8,861
    Amortization of acquired
     technology and other intangibles            566          581
      Total operating expenses                52,182       59,140

    Interest and other
     income (expense), net                    (1,090)       2,066
    Net loss                                 (50,614)     (54,465)
    Dividends on redeemable
     convertible preferred stock                   -         (540)
    Net loss allocable to
     common stockholders                    $(50,614)    $(55,005)

    Net loss per share allocable to common
     stockholders, basic and diluted          $(0.68)      $(0.75)

    Shares used in calculating 
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
2. Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
3. Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
4. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
5. Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008
6. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
7. Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
10. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
11. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo ... institutes from the National Institutes of Health (NIH) to ... more effective treatments to patients on a faster timeline. ... Translational Sciences (NCATS) and the National Eye Institute (NEI) ...
(Date:1/14/2014)... 2014 In recent years, growing suspicion ... in product development and promotion has led to unprecedented ... fueled by concerns about the insidious impact of commercialization ... spectacular fines to the world’s biggest pharmas for illegal ...
(Date:1/14/2014)... Rockville, MD (PRWEB) January 14, 2014 ... dedicated to developing innovative information technology solutions for ... other health care stakeholders, announced today the signing ... the US Food and Drug Administration (FDA). ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... pace of growing computing power could be sustained for ... from the UK,s National Physical Laboratory (NPL) that is ... observed that the density of transistors on an integrated ... time to achieve this, but experts believed that when ...
... OMAHA, Neb., Dec. 9 Transgenomic, Inc.,(OTC Bulletin ... been,awarded an accreditation by the Commission on Laboratory ... on the results of a recent,on-site inspection. Transgenomic ... laboratories nationwide. , Craig Tuttle, CEO ...
... Kingdom and MONTREAL, Dec. 9 /PRNewswire-FirstCall/ - ProMetic ... U.K.-based subsidiary, ProMetic BioSciences Ltd ("PBL"), has signed ... world-leading European Biopharmaceutical company estimated to be worth ... years, with first shipment delivery starting this quarter. ...
Cached Biology Technology:Transgenomic Receives Accreditation From College of American Pathologists 2Transgenomic Receives Accreditation From College of American Pathologists 3ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company 2ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company 3
(Date:4/24/2014)... State University and the University of North Carolina at ... could help identify arterial plaque that is at high ... stroke. , At issue is the plaque that builds ... plaque are deemed "vulnerable," meaning that they are more ... heart attack or stroke. , "Existing state-of-the-art technologies are ...
(Date:4/24/2014)... RICHLAND, Wash. A common plant puts out a welcome ... the mat,s molecular mix. , The study published this week ... reveals new targets during the battle between microbe and ... team showed that the humble and oft-studied plant Arabidopsis ... from a pathogen. It,s as if a hostile army were ...
(Date:4/23/2014)... German . Man ... difference between sexes depends on one single element of the genome: ... two sexual chromosomes are X and Y, whereas women have two ... morphological and physiological differences between males and females. , But this ... the X and Y were identical, until the Y started to ...
Breaking Biology News(10 mins):New ultrasound device may add in detecting risk for heart attack, stroke 2How a plant beckons the bacteria that will do it harm 2How a plant beckons the bacteria that will do it harm 3Male or female? 2Male or female? 3
... the diet for Thanksgiving? Turkey with all the fixings ... their goals, according to a new Cornell University review ... willpower every day. "We,re slaves to our environment," ... psychology at Cornell, who co-authored the article with graduate ...
... WASHINGTON, Nov. 16, 2011 A new episode ... Challenges/Chemistry Solutions" podcast series spins a real-life tale ... major barrier to the use of gene therapy in ... largest scientific society explains in non-technical language that gene ...
... DURHAM, New Hampshire, November 16, 2011 A study ... Thursday, Nov. 17, concludes that forests influence temperature, and ... Hollinger, a plant physiologist with the U.S. Forest Service,s ... Xuhui Lee, a professor of meteorology at the Yale ...
Cached Biology News:New American Chemical Society podcast: Genetically-engineered spider silk for gene therapy 2Forests cooler or warmer than open areas depending on latitude, study finds 2
... The transformation of Saccharomyces cerevisiae, as ... routine procedure in many molecular biology laboratories. ... high efficiencies with plasmid and linear DNAs ... has made routine plasmid transformations and library ...
...
... jetSI-ENDO-FluoF is a ... nm; emission at 520 nm), ... These reagents are used to ... investigate the intracellular delivery and ...
... R&D Systems Cell and Tissue Staining Kits ... a broad range of histological and cytological ... primary IgG antibodies manufactured by either R&D ... is based on the formation of the ...
Biology Products: